Skip to content
Peptigraph home
Shop Peptides50% off*

GHK-Cu Benefits: Claims vs What Studies Show

Benefits people claim for GHK-Cu, set against what published studies measured, and where no study exists.

Medical review pendingCopper tripeptideUpdated
Strongest evidence
Human RCT
Human / animal studies
5 / 7
in our evidence file (PubMed search, 11 Oct 2026)
FDA status
Not approved
Off Category 2, 15 Apr 2026

Claimed benefits and what studies show

Each row is an area where people claim a benefit, with the strongest study we summarise behind it. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

GHK-Cu claimed benefits and the studies behind them
ClaimBest evidenceStudies (human / animal)What was measuredPage
SkinHuman RCT evidence, 4 of 43 / 3Erythema resolution; Patient-reported skin quality; Plantar ulcer closureEvidence for skin
HealingHuman RCT evidence, 4 of 41 / 4Plantar ulcer closure; Ulcer infection; Scald wound healing timeEvidence for healing
Hair growthHuman observational evidence, 3 of 41 / 0Hair fall (pull test)Evidence for hair growth
InflammationAnimal evidence, 2 of 40 / 3Colitis severity and mucosal repair; Lung inflammation and fibrosis; Lung inflammationEvidence for inflammation
Gut healthAnimal evidence, 2 of 40 / 1Colitis severity and mucosal repairEvidence for gut health

Strongest study per claim: Skin, Archives of facial plastic surgery 2006, PMID 16847171; Healing, Wound repair and regeneration 1994, PMID 17147644; Hair growth, Journal of cosmetic and laser therapy 2018, PMID 29482481.

What the studies measured

GHK-Cu outcomes in published studies
OutcomeResultStudy typeSource
Erythema resolutionNo significant difference between groups in erythema resolution on computer analysis and blinded evaluation.Human RCTn = 13Archives of facial plastic surgery 2006, PMID 16847171
Patient-reported skin qualityPatients using GHK-Cu skin care products reported significantly greater improvement in overall skin quality (P = .04), but blinded and objective evaluation found no group difference in wrinkles or skin quality.Human RCTn = 13Archives of facial plastic surgery 2006, PMID 16847171
Plantar ulcer closureMedian ulcer area closure was 98.5% with the GHK-copper gel versus 60.8% with vehicle (p < 0.05).Human RCTWound repair and regeneration 1994, PMID 17147644
Ulcer infectionUlcer infections occurred in 7% with the gel versus 34% with vehicle among ulcers treated immediately after debridement (p < 0.05).Human RCTWound repair and regeneration 1994, PMID 17147644
Hair fall (pull test)Hair fall was significantly reduced in 83% of patients on the pull test after injections of a multi-ingredient formulation that included a copper tripeptide (no control group).Human uncontrolled trialn = 1000Journal of cosmetic and laser therapy 2018, PMID 29482481
Patient satisfaction (combination therapy)Ninety-six and 80 percent of patients reported satisfaction after six and 12 months (combination therapy, not GHK-Cu alone).Human observationaln = 18918The Journal of clinical and aesthetic dermatology 2018, PMID 30057663
Crow's feet wrinklesIn one patient, photographs showed greatly decreased wrinkles around the treated eye after a multi-ingredient cosmetic treatment.Human case reportn = 1Journal of cosmetic and laser therapy 2016, PMID 27064823
State of the human evidenceThe review states the human literature is thin and fragmented; most randomized trials are small facial cosmetic cream studies.Systematic reviewArchives of internal medicine research 2026, PMID 42787770
Clinical evidence for wrinklesThe review reports a surprising absence of clinical studies of GHK-Cu and Pal-GHK for wrinkles.ReviewBioImpacts 2025, PMID 39963574
Colitis severity and mucosal repairGHK-Cu reduced weight loss, disease activity and colonic inflammatory damage and promoted mucosal repair in DSS colitis mice.Animal · mouse (plus mouse cell co-culture) (not a human result)Frontiers in pharmacology 2025, PMID 40672369
Lung inflammation and fibrosisGHK-Cu reduced lung inflammation and fibrosis in silicosis mice without significant systemic toxicity.Animal · mouse (plus macrophage cell line) (not a human result)Redox biology 2024, PMID 38879894
Scald wound healing timeWound healing time was shortened to 14 days with GHK-Cu liposomes in mice.Animal · mouse (plus human umbilical vein endothelial cells) (not a human result)Wound repair and regeneration 2017, PMID 28370978
Lung inflammationGHK-Cu reduced lung histological changes and inflammatory cell infiltration in mice with acute lung injury.Animal · mouse (plus macrophage cell line) (not a human result)Oncotarget 2016, PMID 27517151
Knee laxityKnee laxity was smaller with GHK-Cu at 6 weeks (p = 0.009) but not significantly different at 12 weeks.Animal · rat (not a human result)n = 72Journal of orthopaedic research 2015, PMID 25731775
Wound area reductionBy day 13 wound area had decreased by 64.5% with topical tripeptide-copper, 45.6% with vehicle and 28.2% in untreated controls.Animal · rat (not a human result)n = 24Veterinary surgery 2003, PMID 14648529
Plasma fate of GHKAfter intravenous GHK in rats, GHK was rapidly degraded to its metabolite HK, which was eliminated rapidly. No half-life value is given in the abstract.Animal · rat (not a human result)Journal of chromatography. B, Biomedical sciences and applications 1997, PMID 9187381
TGF-beta1 secretionCopper tripeptide-treated fibroblasts secreted less TGF-beta1 than controls in cell culture.In vitro (not a human result)Archives of facial plastic surgery 2001, PMID 11176716
Not shown in any study we cite. Searches behind this page: PubMed search on 2 Oct 2026 for “("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab])”: 431 results. PubMed search on 2 Oct 2026 for “("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (humans[mh] OR patients[tiab] OR volunteers[tiab])”: 150 results. PubMed search on 2 Oct 2026 for “("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (randomized[tiab] OR clinical trial[pt] OR split-face[tiab])”: 8 results. PubMed search on 2 Oct 2026 for “("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (wound[tiab] OR hair[tiab] OR skin[tiab] OR wrinkle*[tiab])”: 123 results.

The skin and wrinkle claim: one small randomized trial missed its objective endpoints

In a small randomized trial after CO2 laser resurfacing, objective measures found no gain from GHK-Cu skin care, though patients were more satisfied.[1]

The same trial found no statistically significant difference in how fast redness resolved.[1]

A published case report describes a single man treated weekly with a mixed cosmetic solution that contained copper-GHK among four other ingredients, so the result cannot be attributed to GHK-Cu alone.[5]

A review of topical GHK notes that the clinical studies one would expect behind anti-wrinkle products are largely missing.[7]

The wound-healing claim: a 1994 diabetic ulcer trial plus rodent work

In a placebo-controlled trial of diabetic neuropathic foot ulcers, the GHK-copper gel arm had higher median closure than vehicle.[2]

The same trial reported fewer ulcer infections with the gel when it was started immediately after debridement.[2]

In rats with ischemic skin wounds, the gel group's wounds had shrunk more by day 13 than vehicle or untreated wounds.[13]

In mice with scald wounds, a liposome form of the complex shortened healing time to 14 days after injury.[10]

Hair, joint, lung and gut claims

The human hair data come from an uncontrolled pilot of scalp injections of a mixture of six ingredients, and GHK-Cu was only one of them.[3]

That single-arm pilot reported less hair fall on a pull test in most of its patients, with no GHK-Cu-only comparison.[3]

The joint-type claim is represented by a rat knee-ligament reconstruction study in which the benefit faded after the injections stopped.[12]

The anti-inflammatory claim rests on mouse lung-injury work in which the complex lowered inflammatory signals.[11]

The gut claim rests on a mouse model of ulcerative colitis, not on people.[8]

How thin the human literature is

A systematic review of the GHK-Cu literature calls the human literature thin and mostly small cosmetic-cream trials.[6]

A PubMed title/abstract search on 2 Oct 2026 for GHK-Cu terms combined with randomized, clinical trial or split-face returned 8 records, against 431 for the peptide overall.

Calculated from search GHK-Cu terms AND (randomized[tiab] OR clinical trial[pt] OR split-face[tiab]); date 2026-10-02; count 8; total peptide records 431; source web/src/data/evidence/ghk-cu.json searches. Formula: share = count / totalPeptideRecords = 8 / 431

More on GHK-Cu

DosageSide effectsResultsHow it works

Common questions

Is GHK-Cu proven to work?

The strongest study we summarise for GHK-Cu is human rct evidence, among 15 studies. A trial result is not an approval; see the legal status.

What does GHK-Cu do?

A review describes it as a naturally occurring human tripeptide whose copper-bound form has decades of laboratory evidence for tissue regeneration.[6]

Do copper peptides actually work for anti-aging?

The skin-care trial in this cache found patients more satisfied but objective wrinkle measures unchanged.[1]

More on GHK-Cu

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.Side effectsWhat labels and studies report, and what is unknown.ResultsStudy outcomes and when they were measured.How it worksTarget, mechanism and how long it acts, from the label or studies.TopicalStudies that gave GHK-Cu as creams and serums, and what is approved.

Sources

  1. 1Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin.Archives of facial plastic surgery · 2006PMID 16847171Accessed 2 Oct 2026
  2. 2Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 1994PMID 17147644Accessed 2 Oct 2026
  3. 3Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study.Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology · 2018PMID 29482481Accessed 2 Oct 2026
  4. 4Androgenetic Alopecia Treatment in Asian Men.The Journal of clinical and aesthetic dermatology · 2018PMID 30057663Accessed 11 Oct 2026
  5. 5Significant improvement in crow's feet after treatment with Jet-M and a mixed solution of copper-GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation).Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology · 2016PMID 27064823Accessed 2 Oct 2026
  6. 6A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials.Archives of internal medicine research · 2026PMID 42787770Accessed 2 Oct 2026
  7. 7Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.BioImpacts : BI · 2025PMID 39963574Accessed 2 Oct 2026
  8. 8Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms.Frontiers in pharmacology · 2025PMID 40672369Accessed 2 Oct 2026
  9. 9The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6.Redox biology · 2024PMID 38879894Accessed 2 Oct 2026
  10. 10GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 2017PMID 28370978Accessed 2 Oct 2026
  11. 11The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice.Oncotarget · 2016PMID 27517151Accessed 2 Oct 2026
  12. 12Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2015PMID 25731775Accessed 2 Oct 2026
  13. 13The effect of topical tripeptide-copper complex on healing of ischemic open wounds.Veterinary surgery : VS · 2003PMID 14648529Accessed 2 Oct 2026
  14. 14Simultaneous determination of glycyl-L-histidyl-L-lysine and its metabolite, L-histidyl-L-lysine, in rat plasma by high-performance liquid chromatography with post-column derivatization.Journal of chromatography. B, Biomedical sciences and applications · 1997PMID 9187381Accessed 2 Oct 2026
  15. 15The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model.Archives of facial plastic surgery · 2001PMID 11176716Accessed 2 Oct 2026
  16. 16PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) (431 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  17. 17PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (humans[mh] OR patients[tiab] OR volunteers[tiab]) (150 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  18. 18PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (randomized[tiab] OR clinical trial[pt] OR split-face[tiab]) (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  19. 19PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (wound[tiab] OR hair[tiab] OR skin[tiab] OR wrinkle*[tiab]) (123 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  20. 20PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  21. 21PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (rat[tiab] OR mice[tiab] OR rats[tiab] OR animal[tiab]) (80 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  22. 22PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (facial[tiab] OR cream[tiab] OR photodamage[tiab] OR volunteers[tiab] OR women[tiab]) (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  23. 23PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (hair[tiab] OR alopecia[tiab]) (16 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  24. 24PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (38 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026

Found an error? Report a correction.